Correlation Between SCANDMEDICAL SOLDK-040 and Atos SE

Can any of the company-specific risk be diversified away by investing in both SCANDMEDICAL SOLDK-040 and Atos SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANDMEDICAL SOLDK-040 and Atos SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SCANDMEDICAL SOLDK 040 and Atos SE, you can compare the effects of market volatilities on SCANDMEDICAL SOLDK-040 and Atos SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANDMEDICAL SOLDK-040 with a short position of Atos SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANDMEDICAL SOLDK-040 and Atos SE.

Diversification Opportunities for SCANDMEDICAL SOLDK-040 and Atos SE

-0.2

Correlation Coefficient

SCANDMEDICAL SOLDK-040  Atos SE

Good diversification

The 3 months correlation between SCANDMEDICAL and Atos is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding SCANDMEDICAL SOLDK 040 and Atos SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atos SE and SCANDMEDICAL SOLDK-040 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANDMEDICAL SOLDK 040 are associated (or correlated) with Atos SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atos SE has no effect on the direction of SCANDMEDICAL SOLDK-040 i.e., SCANDMEDICAL SOLDK-040 and Atos SE go up and down completely randomly.

Pair Corralation between SCANDMEDICAL SOLDK-040 and Atos SE

Assuming the 90 days horizon SCANDMEDICAL SOLDK 040 is expected to under-perform the Atos SE. But the stock apears to be less risky and, when comparing its historical volatility, SCANDMEDICAL SOLDK 040 is 2.87 times less risky than Atos SE. The stock trades about -0.06 of its potential returns per unit of risk. The Atos SE is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  0.24  in Atos SE on December 23, 2024 and sell it today you would earn a total of  0.15  from holding Atos SE or generate 62.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

SCANDMEDICAL SOLDK 040  vs.  Atos SE

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Atos SE

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Atos SE are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Atos SE reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SCANDMEDICAL SOLDK-040 and Atos SE

The main advantage of trading using opposite SCANDMEDICAL SOLDK-040 and Atos SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANDMEDICAL SOLDK-040 position performs unexpectedly, Atos SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atos SE will offset losses from the drop in Atos SE's long position.

The idea behind SCANDMEDICAL SOLDK 040 and Atos SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.